Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Immunohistochemical diagnostic and prognostic markers for melanoma.

Nosrati M, Kashani-Sabet M.

Methods Mol Biol. 2014;1102:259-73. doi: 10.1007/978-1-62703-727-3_14.

PMID:
24258983
2.

Skin layer-specific Melan-A expression during progression of human cutaneous melanoma: implications for diagnostic applications of the marker.

Sztramska A, Dymerska D, Chwirot BW.

Melanoma Res. 2008 Aug;18(4):259-67. doi: 10.1097/CMR.0b013e328303beac.

PMID:
18626310
3.

Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.

Nazarian RM, Prieto VG, Elder DE, Duncan LM.

J Cutan Pathol. 2010 Apr;37 Suppl 1:41-7. doi: 10.1111/j.1600-0560.2010.01505.x.

PMID:
20482674
4.
5.

Systematic search for the best gene expression markers for melanoma micrometastasis detection.

Soikkeli J, Lukk M, Nummela P, Virolainen S, Jahkola T, Katainen R, Harju L, Ukkonen E, Saksela O, Hölttä E.

J Pathol. 2007 Oct;213(2):180-9.

PMID:
17891747
6.

Expression of Sox-9 in metastatic melanoma--a potential diagnostic pitfall.

Rao P, Fuller GN, Prieto VG.

Am J Dermatopathol. 2010 May;32(3):262-6. doi: 10.1097/DAD.0b013e3181b7fc8d.

PMID:
20098296
7.

Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.

de Vries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ, van Muijen GN.

Cancer Res. 1997 Aug 1;57(15):3223-9.

8.

Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.

Mason A, Wititsuwannakul J, Klump VR, Lott J, Lazova R.

J Cutan Pathol. 2012 Dec;39(12):1062-74. doi: 10.1111/cup.12014.

PMID:
23005921
9.
10.

Accurate identification of proliferative index in melanocytic neoplasms with Melan-A/Ki-67 double stain.

Puri PK, Valdes CL, Burchette JL, Grichnik JM, Turner JW, Selim MA.

J Cutan Pathol. 2010 Sep;37(9):1010-2. doi: 10.1111/j.1600-0560.2009.01487.x. No abstract available.

PMID:
20002650
11.

Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma.

Meyer S, Wild PJ, Vogt T, Bataille F, Ehret C, Gantner S, Landthaler M, Klinkhammer-Schalke M, Hofstaedter F, Bosserhoff AK.

Exp Dermatol. 2010 Aug;19(8):e251-7. doi: 10.1111/j.1600-0625.2010.01072.x.

12.

Wilms tumor 1 expression present in most melanomas but nearly absent in nevi.

Perry BN, Cohen C, Govindarajan B, Cotsonis G, Arbiser JL.

Arch Dermatol. 2006 Aug;142(8):1031-4.

PMID:
16924053
13.

Melanoma or not? Cancer testis antigens may help.

Lüftl M, Schuler G, Jungbluth AA.

Br J Dermatol. 2004 Dec;151(6):1213-8.

PMID:
15606517
14.

The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.

Garrido-Ruiz MC, Requena L, Ortiz P, Pérez-Gómez B, Alonso SR, Peralto JL.

Mod Pathol. 2010 Sep;23(9):1215-24. doi: 10.1038/modpathol.2010.102.

15.

Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.

Setia N, Abbas O, Sousa Y, Garb JL, Mahalingam M.

Mod Pathol. 2012 Aug;25(8):1169-75. doi: 10.1038/modpathol.2012.71.

16.

Transcription factors and other dysregulated proteins in melanoma prognosis.

Karjalainen JM.

Curr Oncol Rep. 2001 Jul;3(4):368-75. Review.

PMID:
11389823
17.

[Malignant melanoma: conceptual and therapeutic innovations based on translational research].

Piérard GE, Quatresooz P, Rorive A, Piérard-Franchimont C; Groupe Mosan D'Etude des Tumeurs Pigmentaires..

Rev Med Liege. 2008 Oct;63(10):579-84. Review. French.

PMID:
19009964
18.

Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis.

King R, Weilbaecher KN, McGill G, Cooley E, Mihm M, Fisher DE.

Am J Pathol. 1999 Sep;155(3):731-8.

19.

Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.

Lohmann CM, Iversen K, Jungbluth AA, Berwick M, Busam KJ.

Am J Surg Pathol. 2002 Oct;26(10):1351-7.

PMID:
12360050
20.

Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions.

Nielsen PS, Riber-Hansen R, Steiniche T.

Am J Dermatopathol. 2011 Jun;33(4):361-70. doi: 10.1097/DAD.0b013e3182120173.

PMID:
21610457
Items per page

Supplemental Content

Support Center